We applaud Maryland Governor Larry Hogan for joining 28 other states in creating a pathway for the substitution of biologic medications with biosimilars by signing the Pharmacists – Substitution and Dispensing of Biological Products bill into law.
Biologics are life altering drugs for people with arthritis and are very complex products made with living cells. Because of this complexity they are expensive. Biosimilars, are a new class of drugs that are similar to biologics. They have the potential to lower medication costs.
Continue reading Victory for Maryland! Biosimilar Bill Signed by the Governor!
Iowa has recently joined 27 other states that have passed biosimilars legislation. On behalf of the 619,000 adults (plus 2,800 children) in Iowa with doctor-diagnosed arthritis, we’d like to thank Governor Branstad for signing House File 305 into law on Friday, March 10, 2017.
The bill allows Iowa pharmacists the ability to dispense safe and potentially less expensive biologic medications to patients, by substituting an FDA approved interchangeable biosimilar for a prescribed biologic product. The law also requires that the prescriber and patient be notified when there is a substitution.
Continue reading Victory in Iowa: Biosimilar Legislation Signed Into Law!
For years now, many arthritis patients have utilized biologic medications to great effect. Biologics have allowed those with arthritis, as well as many other chronic diseases, to stabilize their condition and help them better quality lives. Now, due to innovation, new medications are coming to market which could provide arthritis patients with more, and potentially less expensive, options. These new medications are called “biosimilar” medications which are similar to, but not exact copies of name brand biologics.
Continue reading Victory in Montana! Governor Bullock Signs Biosimilar Substitution
Imagine that your pharmacist substituted the biologic drug prescribed by your physician for a different drug, an interchangeable biologic product, without your physician being informed. For many people in Ohio who are taking biologic drugs, this scary scenario was a potential reality.
Continue reading Ohio Biosimilar Substitution bill signed into Law by Governor Kasich
With new, innovative arthritis medications coming to market, patients with arthritis may soon have access to potentially less expensive biosimilar medications. These are medications that are similar but not exact copies of name brand biologics.
Continue reading Biosimilar Substitution Victory in Hawaii!
Devon Salasin is a junior at Penn State University and a talented snow skier. So good, that she recently placed 23rd out of 107 skiers at the National Collegiate Alpine Race. But skiing wasn’t always fun or easy for Devon.
In 2011, Devon was diagnosed with juvenile rheumatoid arthritis (JRA). Overnight she went from a carefree kid pursuing her snow ski racing passion to a kid burdened with pain, swollen and deteriorating joints, and fatigue.
Continue reading Pennsylvania Arthritis Advocates Achieve Biosimilar Substitution Success!
Kyleigh O’Brien is an 11-year-old with juvenile arthritis and has testified in front of the Missouri legislature twice this year. Why does she do it?
She wants to be a voice for the estimated 300,000 children in the United States who live with arthritis. Kyleigh has advocated most recently for the passage of Missouri Senate Bill 875 (SB 875), which has now been signed into law by Governor Jay Nixon.
Continue reading Breaking Advocacy News in Missouri – Senate Bill 875 Regarding Biosimilars has Been Signed Into Law!
Big news for our arthritis community in Kentucky! On April 13, 2016, Gov. Matt Bevin (R – KY) signed Senate Bill 134 into law. The law creates a pathway for the introduction and use of biosimilars into the mainstream marketplace. Biosimilar medications have the potential to provide safe and effective treatment to people with arthritis at a potentially lower cost than name-brand biologic medications.
The many letters, calls and visits made by Arthritis Foundation Advocates in Kentucky played a significant role in the passage of SB 134.
Continue reading Advocates in Kentucky Get a Big Win for Biosimilar Substitution